Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]
Titel:
Erratum to “Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan” [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1063-1075]
Auteur:
Uchiyama, Kiyotaka Kamano, Daisuke Nagasaka, Tomoki Hama, Eriko Yoshida Shirai, Ryoichi Sumura, Rena Kusahana, Ei Yanai, Akane Nakayama, Takashin Kimura, Takahide Takahashi, Rina Kasai, Takahiro Tajima, Takaya Hosoya, Koji Azegami, Tatsuhiko Yamaguchi, Shintaro Yoshino, Jun Ito, Jun Hayashi, Matsuhiko Kanda, Takeshi Ishibashi, Yoshitaka Washida, Naoki Itoh, Hiroshi Hayashi, Kaori